Yasuda Shusuke 安田周祐

… Alternative Names

YASUDA SHUSUKE 安田周祐

Less

Researcher Number	10643398
Affiliation (Current)	2025: 京都府立医科大学, 医学(系)研究科(研究院), 助教
Affiliation (based on the past Project Information) *help	2019 – 2025: 京都府立医科大学, 医学(系)研究科(研究院), 助教 2013 – 2014: 京都府立医科大学, 医学(系)研究科(研究院), 研究員
Review Section/Research Field	Principal Investigator Basic Section 58020:Hygiene and public health-related: including laboratory approach / Hygiene and public health Except Principal Investigator Basic Section 58020:Hygiene and public health-related: including laboratory approach / Medium-sized Section 58:Society medicine, nursing, and related fields / Complex systems
Keywords	Principal Investigator アポトーシス / 癌予防 / TRAIL / 悪性腫瘍 Except Principal Investigator RB / がん予防 / 先制医療 / 膵NET / MEN1 / 予防 … More / がん / Eomes / T-bet / IL-6 / 天然物 / 細胞老化 / NK細胞 / ケミカルバイオロジー / スクリーニング / SASP / TRAIL / ヒ素 / 家族性大腸腺腫症 / リ・フラウメニ症候群 / がん体質診断 / テーラーメイドがん予防 Less

家族性大腸腺腫症に対する先制医療の開発Principal Investigator
- Principal Investigator
  
  安田周祐
- Project Period (FY)
  2025 – 2027
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 58020:Hygiene and public health-related: including laboratory approach
- Research Institution
  Kyoto Prefectural University of Medicine
Development of preemptive medical care for pre-symptomatic MEN1 gene mutation carriers
- Principal Investigator
  
  堀中真野
- Project Period (FY)
  2023 – 2026
- Research Category
  
  Grant-in-Aid for Scientific Research (B)
- Review Section
  
  Basic Section 58020:Hygiene and public health-related: including laboratory approach
- Research Institution
  Kyoto Prefectural University of Medicine
Development of preemptive medicine against RB-mutated malignancies
- Principal Investigator
  
  酒井敏行
- Project Period (FY)
  2022 – 2027
- Research Category
  
  Grant-in-Aid for Challenging Research (Pioneering)
- Review Section
  
  Medium-sized Section 58:Society medicine, nursing, and related fields
- Research Institution
  Kyoto Prefectural University of Medicine
Tailor-maid cancer prevention towards the era of preemptive medicine.
- Principal Investigator
  
  Sakai Toshiyuki
- Project Period (FY)
  2019 – 2023
- Research Category
  
  Grant-in-Aid for Scientific Research (A)
- Review Section
  
  Medium-sized Section 58:Society medicine, nursing, and related fields
- Research Institution
  Kyoto Prefectural University of Medicine
Preventive strategy against arsenic carcinogenesis by TRAIL pathway activation and RB activation
- Principal Investigator
  
  Horinaka Mano
- Project Period (FY)
  2019 – 2022
- Research Category
  
  Grant-in-Aid for Scientific Research (B)
- Review Section
  
  Basic Section 58020:Hygiene and public health-related: including laboratory approach
- Research Institution
  Kyoto Prefectural University of Medicine
Research of molecular-targeting prevention against inflammatory diseases using chemical biology.
- Principal Investigator
  
  Sakai Toshiyuki
- Project Period (FY)
  2017 – 2021
- Research Category
  
  Grant-in-Aid for Scientific Research on Innovative Areas (Research in a proposed research area)
- Review Section
  
  Complex systems
- Research Institution
  Kyoto Prefectural University of Medicine
Sulforaphane enhances apoptosis induced by Lactobacillus via TNF-alpha pathway in human colon cancer cells.Principal Investigator
- Principal Investigator
  
  YASUDA SHUSUKE
- Project Period (FY)
  2013 – 2014
- Research Category
  
  Grant-in-Aid for Young Scientists (B)
- Research Field
  
  Hygiene and public health
- Research Institution
  Kyoto Prefectural University of Medicine

All 2024 2023 2022 2021 2020 2019 2018

All Journal Article Presentation

[Journal Article] Discovery of cancer-preventive juices reactivating RB functions2023
- Author(s)
  Masuda M, Horinaka M, Yasuda S, Morita M, Nishimoto E, Ishikawa H, Mutoh M, Sakai T
- Journal Title
  
  Environ Health Prev Med
  
  Volume: 28 Issue: 0 Pages: 54-54
- DOI
  10.1265/ehpm.23-00160
- ISSN
  1342-078X, 1347-4715
- Language
  English
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-22K18407, KAKENHI-PROJECT-19H01079, KAKENHI-PROJECT-23K27841
[Journal Article] Oridonin inhibits SASP by blocking p38 and NF-κB pathways in senescent cells2022
- Author(s)
  Yasuda Shusuke、Horinaka Mano、Iizumi Yosuke、Goi Wakana、Sukeno Mamiko、Sakai Toshiyuki
- Journal Title
  
  Biochemical and Biophysical Research Communications
  
  Volume: 590 Pages: 55-62
- DOI
  10.1016/j.bbrc.2021.12.098
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-ORGANIZER-17H06391, KAKENHI-PLANNED-17H06398, KAKENHI-PROJECT-19H01079, KAKENHI-PROJECT-19H03889
[Journal Article] The Rationale for the Dual-Targeting Therapy for RSK2 and AKT in Multiple Myeloma.2022
- Author(s)
  Isa R, Horinaka M, Tsukamoto T, Mizuhara K, Fujibayashi Y, Taminishi-Katsuragawa Y, Okamoto H, Yasuda S, Kawaji-Kanayama Y, Matsumura-Kimoto Y, Mizutani S, Shimura Y, Taniwaki M, Sakai T, Kuroda J.
- Journal Title
  
  Int J Mol Sci.
  
  Volume: 23 Issue: 6 Pages: 2919-2936
- DOI
  10.3390/ijms23062919
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-19K08872, KAKENHI-PLANNED-17H06398, KAKENHI-PROJECT-19H01079, KAKENHI-PROJECT-19H03889, KAKENHI-PROJECT-21K16246, KAKENHI-PROJECT-21K16274
[Journal Article] Salicylic acid directly binds to ribosomal protein S3 and suppresses CDK4 expression in colorectal cancer cells2022
- Author(s)
  Imai A, Horinaka M, Aono Y, Iizumi Y, Takakura H, Ono H, Yasuda S, Taniguchi K, Nishimoto E, Ishikawa H, Mutoh M, Sakai T
- Journal Title
  
  Biochemical and Biophysical Research Communications
  
  Volume: 628 Pages: 110-115
- DOI
  10.1016/j.bbrc.2022.08.082
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22K18407, KAKENHI-PROJECT-22K17350, KAKENHI-PROJECT-19H01079, KAKENHI-PROJECT-19H03889
[Journal Article] Novel RAF/MEK inhibitor CH5126766/VS‐6766 has efficacy in combination with eribulin for the treatment of triple‐negative breast cancer2021
- Author(s)
  Ono H, Horinaka M, Sukeno M, Morita M, Yasuda S, Nishimoto E, Konishi E, Sakai T
- Journal Title
  
  Cancer Science
  
  Volume: 112 Issue: 10 Pages: 4166-4175
- DOI
  10.1111/cas.15071
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PLANNED-17H06398, KAKENHI-PROJECT-19H01079, KAKENHI-PROJECT-19H03889, KAKENHI-PROJECT-20K18906
[Journal Article] The HDAC inhibitor OBP-801 suppresses the growth of myxofibrosarcoma cells.2020
- Author(s)
  Kawarazaki A, Horinaka M, Yasuda S, Kawashima H, Numajiri T, Sakai T.
- Journal Title
  
  J BUON.
  
  Volume: 25 Pages: 464-471
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PLANNED-17H06398
[Journal Article] The HDAC inhibitor OBP-801 suppresses the growth of myxofibrosarcoma cells.2020
- Author(s)
  Kawarazaki A, Horinaka M, Yasuda S, Kawashima H, Numajiri T, Sakai T.
- Journal Title
  
  J BUON
  
  Volume: 25 Pages: 464-471
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-19H03889
[Journal Article] The HDAC inhibitor OBP-801 suppresses the growth of myxofibrosarcoma cells.2020
- Author(s)
  Kawarazaki A, Horinaka M, Yasuda S, Kawashima H, Numajiri T, Sakai T.
- Journal Title
  
  J BUON.
  
  Volume: 25 Pages: 464-471
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-19H01079
[Journal Article] Cycloartenyl Ferulate and β-Sitosteryl Ferulate - Steryl Ferulates of γ-Oryzanol - Suppress Intracellular Reactive Oxygen Species in Cell-based System2019
- Author(s)
  Yasuda S, Sowa Y, Hashimoto H, Nakagami T, Tsuno T, Sakai T.
- Journal Title
  
  J. Oleo Sci.
  
  Volume: 68 Issue: 8 Pages: 765-768
- DOI
  10.5650/jos.ess19054
- NAID
  130007686318
- ISSN
  1345-8957, 1347-3352
- Language
  English
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PLANNED-17H06398, KAKENHI-PROJECT-19H01079
[Journal Article] Sulforaphane enhances apoptosis induced by Lactobacillus pentosus strain S-PT84 via the TNFα pathway in human colon cancer cells.2019
- Author(s)
  Yasuda S, Horinaka M, Sakai T.
- Journal Title
  
  Oncol Lett.
  
  Volume: 18 Pages: 4253-4261
- DOI
  10.3892/ol.2019.10739
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PLANNED-17H06398, KAKENHI-PROJECT-19H01079, KAKENHI-PROJECT-19H03889
[Journal Article] Sulindac sulfone inhibits the mTORC1 pathway in colon cancer cells by directly targeting voltage-dependent anion channel 1 and 22018
- Author(s)
  Aono Yuichi、Horinaka Mano、Iizumi Yosuke、Watanabe Motoki、Taniguchi Tomoyuki、Yasuda Shusuke、Sakai Toshiyuki
- Journal Title
  
  Biochemical and Biophysical Research Communications
  
  Volume: 505 Issue: 4 Pages: 1203-1210
- DOI
  10.1016/j.bbrc.2018.10.050
- Peer Reviewed
- Data Source
  KAKENHI-ORGANIZER-17H06391, KAKENHI-PLANNED-17H06398, KAKENHI-PROJECT-16H05260, KAKENHI-PROJECT-17K19829
[Presentation] RB再活性化能を有する果実とTRAIL誘導能を有する乳酸菌による新規がん予防戦略2024
- Author(s)
  堀中真野, 増田光治, 安田周祐, 森田美枝, 西幹栄美, 石川秀樹, 武藤倫弘, 酒井敏行
- Organizer
  第94回日本衛生学会学術総会
- Data Source
  KAKENHI-PROJECT-19H01079
[Presentation] RB再活性化能を有する果実とTRAIL誘導能を有する乳酸菌による新規がん予防戦略2024
- Author(s)
  堀中真野, 増田光治, 安田周祐, 森田美枝, 西幹栄美, 石川秀樹, 武藤倫弘, 酒井敏行
- Organizer
  第94回日本衛生学会学術総会
- Data Source
  KAKENHI-PROJECT-23K27841
[Presentation] 実践的がん予防を目指した、RB再活性化果実飲料の開発2024
- Author(s)
  堀中真野, 増田光治, 安田周祐, 森田美枝, 西幹栄美, 石川秀樹, 武藤倫弘, 酒井敏行
- Organizer
  第23回分子予防環境医学研究会大会
- Data Source
  KAKENHI-PROJECT-22K18407
[Presentation] 実践的がん予防を目指して-RB再活性化果実飲料の開発-2024
- Author(s)
  堀中真野, 増田光治, 安田周祐, 森田美枝, 西幹栄美, 石川秀樹, 武藤倫弘, 酒井敏行
- Organizer
  第94回日本衛生学会学術総会
- Data Source
  KAKENHI-PROJECT-22K18407
[Presentation] 実践的がん予防を目指して-RB再活性化果実飲料の開発-2024
- Author(s)
  堀中真野, 増田光治, 安田周祐, 森田美枝, 西幹栄美, 石川秀樹, 武藤倫弘, 酒井敏行
- Organizer
  第94回日本衛生学会学術総会
- Data Source
  KAKENHI-PROJECT-19H01079
[Presentation] 実践的がん予防を目指して-RB再活性化果実飲料の開発-2024
- Author(s)
  堀中真野, 増田光治, 安田周祐, 森田美枝, 西幹栄美, 石川秀樹, 武藤倫弘, 酒井敏行
- Organizer
  第94回日本衛生学会学術総会
- Data Source
  KAKENHI-PROJECT-23K27841
[Presentation] 実践的がん予防を目指した、RB再活性化果実飲料の開発2024
- Author(s)
  堀中真野, 増田光治, 安田周祐, 森田美枝, 西幹栄美, 石川秀樹, 武藤倫弘, 酒井敏行
- Organizer
  第23回分子予防環境医学研究会大会
- Data Source
  KAKENHI-PROJECT-19H01079
[Presentation] RB再活性化能を有する果実とTRAIL誘導能を有する乳酸菌による新規がん予防戦略2024
- Author(s)
  堀中真野, 増田光治, 安田周祐, 森田美枝, 西幹栄美, 石川秀樹, 武藤倫弘, 酒井敏行
- Organizer
  第94回日本衛生学会学術総会
- Data Source
  KAKENHI-PROJECT-22K18407
[Presentation] 実践的がん予防を目指した、RB再活性化果実飲料の開発2024
- Author(s)
  堀中真野, 増田光治, 安田周祐, 森田美枝, 西幹栄美, 石川秀樹, 武藤倫弘, 酒井敏行
- Organizer
  第23回分子予防環境医学研究会大会
- Data Source
  KAKENHI-PROJECT-23K27841
[Presentation] RB再活性化ジュースの発見2023
- Author(s)
  増田光治, 堀中真野, 安田周祐, 森田美枝, 西幹栄美, 石川秀樹, 武藤倫弘, 酒井敏行
- Organizer
  第82回日本癌学会学術総会
- Data Source
  KAKENHI-PROJECT-23K27841
[Presentation] RB再活性化ジュースの発見2023
- Author(s)
  増田光治, 堀中真野, 安田周祐, 森田美枝, 西幹栄美, 石川秀樹, 武藤倫弘, 酒井敏行
- Organizer
  第82回日本癌学会学術総会
- Data Source
  KAKENHI-PROJECT-22K18407
[Presentation] RB再活性化ジュースの発見2023
- Author(s)
  増田光治, 堀中真野, 安田周祐, 森田美枝, 西幹栄美, 石川秀樹, 武藤倫弘, 酒井敏行
- Organizer
  第82回日本癌学会学術総会
- Data Source
  KAKENHI-PROJECT-19H01079
[Presentation] RB活性化果実飲料の発見2022
- Author(s)
  増田光治, 堀中真野, 安田周祐, 森田美枝, 西幹栄美, 石川秀樹, 武藤倫弘, 酒井敏行
- Organizer
  がん予防学術大会2022
- Data Source
  KAKENHI-PROJECT-19H01079
[Presentation] 延命草成分オリドニンはp38とNF-kBを介して老化関連分泌現象を阻害する2022
- Author(s)
  安田周祐, 堀中真野, 飯泉陽介, 後居和佳奈, 助野真美子, 酒井敏行
- Organizer
  第21回分子予防環境医学研究会大会
- Data Source
  KAKENHI-PROJECT-19H03889
[Presentation] 延命草成分オリドニンはp38とNF-κBを介して老化関連分泌現象を阻害する2022
- Author(s)
  安田周祐, 堀中真野, 飯泉陽介, 後居和佳奈, 助野真美子, 酒井敏行
- Organizer
  第21回分子予防環境医学研究会大会
- Data Source
  KAKENHI-PLANNED-17H06398
[Presentation] サリチル酸はヒト大腸がん細胞のRPS3に結合し、CDK4発現抑制と細胞周期のG1期停止を誘導する2022
- Author(s)
  今井綾香, 堀中真野, 青野裕一, 飯泉陽介, 高倉秀樹, 小野寿子, 谷口恵香, 安田周祐, 西幹栄美, 石川秀樹, 武藤倫弘, 酒井敏行
- Organizer
  がん予防学術大会2022
- Data Source
  KAKENHI-PROJECT-22K18407
[Presentation] 延命草成分オリドニンはp38とNF-κBを介して老化関連分泌現象を阻害する2022
- Author(s)
  安田周祐, 堀中真野, 飯泉陽介, 後居和佳奈, 助野真美子, 酒井敏行
- Organizer
  がん予防学術大会2022
- Data Source
  KAKENHI-PROJECT-22K18407
[Presentation] サリチル酸はヒト大腸がん細胞のRPS3に結合し、CDK4発現抑制と細胞周期のG1期停止を誘導する2022
- Author(s)
  今井綾香, 堀中真野, 青野裕一, 飯泉陽介, 高倉秀樹, 小野寿子, 谷口恵香, 安田周祐, 西幹栄美, 石川秀樹, 武藤倫弘, 酒井敏行
- Organizer
  がん予防学術大会2022
- Data Source
  KAKENHI-PROJECT-19H01079
[Presentation] 延命草成分オリドニンはp38とNF-κBを介して老化関連分泌現象を阻害する2022
- Author(s)
  安田周祐, 堀中真野, 飯泉陽介, 後居和佳奈, 助野真美子, 酒井敏行
- Organizer
  がん予防学術大会2022
- Data Source
  KAKENHI-PROJECT-19H03889
[Presentation] 延命草成分オリドニンはp38とNF-κBを介して老化関連分泌現象を阻害する2022
- Author(s)
  安田周祐, 堀中真野, 飯泉陽介, 後居和佳奈, 助野真美子, 酒井敏行
- Organizer
  第21回分子予防環境医学研究会大会
- Data Source
  KAKENHI-PROJECT-19H01079
[Presentation] サリチル酸はヒト大腸がん細胞のRPS3に結合し、CDK4発現抑制と細胞周期のG1期停止を誘導する2022
- Author(s)
  今井綾香, 堀中真野, 青野裕一, 飯泉陽介, 高倉秀樹, 小野寿子, 谷口恵香, 安田周祐, 西幹栄美, 石川秀樹, 武藤倫弘, 酒井敏行
- Organizer
  がん予防学術大会2022
- Data Source
  KAKENHI-PROJECT-19H03889
[Presentation] RB活性化果実飲料の発見2022
- Author(s)
  増田光治, 堀中真野, 安田周祐, 森田美枝, 西幹栄美, 石川秀樹, 武藤倫弘, 酒井敏行
- Organizer
  がん予防学術大会2022
- Data Source
  KAKENHI-PROJECT-19H03889
[Presentation] RB活性化果実飲料の発見2022
- Author(s)
  増田光治, 堀中真野, 安田周祐, 森田美枝, 西幹栄美, 石川秀樹, 武藤倫弘, 酒井敏行
- Organizer
  がん予防学術大会2022
- Data Source
  KAKENHI-PROJECT-22K18407
[Presentation] 延命草成分オリドニンはp38とNF-κBを介して老化関連分泌現象を阻害する2022
- Author(s)
  安田周祐, 堀中真野, 飯泉陽介, 後居和佳奈, 助野真美子, 酒井敏行
- Organizer
  がん予防学術大会2022
- Data Source
  KAKENHI-PROJECT-19H01079
[Presentation] スリンダク代謝体であるスリンダクスルホンによる大腸腺腫形成抑制作用の機序解明に向けた新規標的分子の同定2019
- Author(s)
  堀中真野，青野裕一，飯泉陽介，安田周祐，渡邉元樹，谷口知行，酒井敏行
- Organizer
  第26回日本がん予防学会総会
- Data Source
  KAKENHI-PROJECT-19H03889
[Presentation] Sulindac sulfone inhibits the mTORC1 pathway in colon cancer cells by directly targeting VDAC1 and VDAC2.2019
- Author(s)
  青野裕一，堀中真野，飯泉陽介，安田周祐，渡邉元樹，酒井敏行
- Organizer
  第78回日本癌学会学術総会
- Data Source
  KAKENHI-PROJECT-19H03889

1. Sakai Toshiyuki (20186993)

# of Collaborated Projects: 5 results

# of Collaborated Products: 32 results
2. Horinaka Mano (80512037)

# of Collaborated Projects: 5 results

# of Collaborated Products: 32 results
3. 鈴木孝禎 (90372838)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
4. 中尾俊雅 (30829320)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
5. 早川芳弘 (10541956)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
6. 飯泉陽介 (20533178)

# of Collaborated Projects: 1 results

# of Collaborated Products: 1 results
7. 谷口恵香 (70882942)

# of Collaborated Projects: 1 results

# of Collaborated Products: 2 results
8. KURODA Junya

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results

Yasuda Shusuke 安田 周祐

YASUDA SHUSUKE 安田 周祐

Research Projects

Research Products

Co-Researchers

家族性大腸腺腫症に対する先制医療の開発Principal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Development of preemptive medical care for pre-symptomatic MEN1 gene mutation carriers

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Development of preemptive medicine against RB-mutated malignancies

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Tailor-maid cancer prevention towards the era of preemptive medicine.

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Preventive strategy against arsenic carcinogenesis by TRAIL pathway activation and RB activation

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Research of molecular-targeting prevention against inflammatory diseases using chemical biology.

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Sulforaphane enhances apoptosis induced by Lactobacillus via TNF-alpha pathway in human colon cancer cells.Principal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

[Journal Article] Discovery of cancer-preventive juices reactivating RB functions2023

Author(s)

Journal Title

DOI

ISSN

Language

Data Source

[Journal Article] Oridonin inhibits SASP by blocking p38 and NF-κB pathways in senescent cells2022

Author(s)

Journal Title

DOI

Data Source

[Journal Article] The Rationale for the Dual-Targeting Therapy for RSK2 and AKT in Multiple Myeloma.2022

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Salicylic acid directly binds to ribosomal protein S3 and suppresses CDK4 expression in colorectal cancer cells2022

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Novel RAF/MEK inhibitor CH5126766/VS‐6766 has efficacy in combination with eribulin for the treatment of triple‐negative breast cancer2021

Author(s)

Journal Title

DOI

Data Source

[Journal Article] The HDAC inhibitor OBP-801 suppresses the growth of myxofibrosarcoma cells.2020

Author(s)

Journal Title

Data Source

[Journal Article] The HDAC inhibitor OBP-801 suppresses the growth of myxofibrosarcoma cells.2020

Author(s)

Yasuda Shusuke 安田周祐

YASUDA SHUSUKE 安田周祐